Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

No significant link was found between the studied genes and female hair loss in the Polish population.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

5-ARI therapy may help prevent prostate cancer progression.

Topical finasteride may help treat facial hirsutism in women.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

A new method was developed to make finasteride for treating hair loss.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

A new compound was made that might help treat diseases related to male hormones.

Hair loss is a common side effect of hormone treatments for cancer.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.